bourva
DSE · DSE Health Care SQURPHARMA

Square Pharmaceuticals PLC share price

SQURPHARMA · Square Pharmaceuticals PLC
BDT 215.00 ▼ BDT 2.86 · -1.31%
Market closed · 08:08 local Jun 26, 2026 Prices delayed ≥15 min Sample data

Price chart

Key statistics

Market cap
BDT 190.49B
P/E (TTM)
10.0×
EPS (TTM)
BDT 21.50
Dividend yield
3.01%
52-week range
BDT 207.29 – BDT 244.69
Avg volume
2.4M
Beta
1.59
Prev close
BDT 217.86

About Square Pharmaceuticals PLC

AI-assisted summary

Square Pharmaceuticals PLC (SQURPHARMA) is a company listed on DSE in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.

Dividend history

Annual payout (TTM): BDT 6.47 · Forward yield: 3.01%
Ex-date Pay date Amount Frequency Dividend yield
Jun 21, 2026 Jun 28, 2026 BDT 6.47 Annual 3.01%
Jun 21, 2025 Jun 28, 2025 BDT 7.52 Annual 3.50%
Jun 21, 2024 Jun 28, 2024 BDT 6.29 Annual 2.93%

Financials

Annual figures, last 5 fiscal years.

Date Revenue Net income EPS (TTM) P/E (TTM)
FY2024 BDT 77.93B BDT 16.20B BDT 15.99 12.8×
FY2023 BDT 66.18B BDT 15.58B BDT 18.13 9.5×
FY2022 BDT 61.41B BDT 8.78B BDT 18.63 12.0×
FY2021 BDT 57.28B BDT 12.68B BDT 21.02 11.4×
FY2020 BDT 49.52B BDT 11.16B BDT 23.83 8.6×

Stock splits

No stock splits on record for Square Pharmaceuticals PLC.

Analyst forecast

12-month price target
BDT 255.82
Consensus rating
Strong buy
Implied upside
+18.99%
Based on 17 analysts
12-month

Aggregated analyst estimates (sample)

Related

Frequently asked questions

What is the current Square Pharmaceuticals PLC share price?

Square Pharmaceuticals PLC (SQURPHARMA) last traded at BDT 215.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.

Does Square Pharmaceuticals PLC pay a dividend?

Yes — Square Pharmaceuticals PLC has a forward dividend yield of about 3.01%, based on its trailing 12-month payout.

What is Square Pharmaceuticals PLC's market capitalisation?

Square Pharmaceuticals PLC has an approximate market capitalisation of BDT 190.49B.

What is Square Pharmaceuticals PLC's P/E ratio?

Square Pharmaceuticals PLC trades at a trailing P/E ratio of about 10.0.

Compare with another ticker
See two tickers side by side — price, valuation and dividends.